US · Healthcare · Medical Devices
EPS came in at -0.15 against a street estimate of -0.13 — a miss of 15.4%.
Analysts rate CapsoVision, Inc. Common Stock a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $9.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 3.56% |
| Vanguard Capital Management, LLC | 1.99% |
| Geode Capital Management, LLC | 1.09% |
| State Street Corp | 0.77% |
| Vanguard Portfolio Management, LLC | 0.45% |
| Northern Trust Corp | 0.41% |
| Vanguard Fiduciary Trust Co | 0.19% |
| Charles Schwab Investment Management Inc | 0.15% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CapsoVision, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.